MACKENZIE DALLAIRE: Open Payments
NPI 1164188520 · CAMDEN, NJ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$900 in 17 payments from 11 companies in 2025. Trend: 2023 $271 · 2024 $646 · 2025 $900
Food & beverage: $900
| Company | Payments | Amount |
|---|---|---|
| Ethicon US, LLC | 2 | $231 |
| Baxter Healthcare | 2 | $211 |
| Haemonetics Corporation | 1 | $159 |
| Medtronic, Inc. | 1 | $101 |
| Ipsen Biopharmaceuticals, Inc | 2 | $42 |
| Madrigal Pharmaceuticals | 2 | $37 |
| Veloxis Pharmaceuticals, Inc. | 2 | $32 |
| Vifor Pharma, Inc. | 2 | $30 |
| Acera Surgical, Inc. | 1 | $23 |
| ORPHALAN INC | 1 | $19 |
Products named: PERCLOT, VISTASEAL, TEG6S HEMOSTASIS SYSTEM, EMPRINT, IQIRVO, REZDIFFRA, ENVARSUS, Veltassa.
Industry payments across NJ — which companies pay providers there.
